Published 2 years ago

U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

Summary by Ground News

Pfizer's Paxlovid is authorised to treat newly infected, at-risk people in order to prevent severe illness. More than 162,000 courses were dispensed last week - compared with an average of 33,000 a week since the drug was launched late last year. But higher use has also come with more reports from people who say their symptoms eased only to return a few days after finishing a five-day regimen.

0 Articles

All

Left

Center

Right

Reuters

U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.

2 years ago·United Kingdom

Read Full Article

Global News

U.S. doctors reconsider use of Pfizer’s COVID-19 pill for lower-risk patients - National | Globalnews.ca

Paxlovid's emergency authorization stipulates that it should be used only for newly infected people with risk factors, but doctors said many others have sought out a prescription.

2 years ago·Toronto, Canada

Read Full Article

The Star Kuala Lumpur

U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

(Reuters) - Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.

2 years ago·Malaysia

Read Full Article

Channel News Asia

US doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

LOS ANGELES: Use of Pfizer's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a US public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time. Mo

2 years ago·Singapore

Read Full Article